The U.S. Food and Drug Administration today published a statement on its website regarding the use of IQOS for smoking. The agency authorized the sale of the tobacco heating system, confirming scientific research by Philip Morris.
The agency also said that the use of IQOS has a positive effect on public health. The U.S. Food and Drug Administration explained the reason for this with three components:
In early April, cigarette manufacturers Philip Morris International Inc. and British American Tobacco Plc said they had started developing a vaccine against the coronavirus disease COVID-19 from tobacco leaves and were already conducting preclinical trials. Philip Morris planned to begin human testing in the summer of this year.
IQOS is a tobacco heating system developed by Philip Morris. The system was first demonstrated in 2014, after which IQOS began to go on sale.